Health surveys find mental disorders highly prevalent and often untreated

Reallocation of treatment resources could substantially decrease the problem of unmet need for treatment of mental disorders among serious cases in developed and developing countries, according to the findings from The World Health Organization (WHO) World Mental Health Surveys published in the June 2 issue of the Journal of the American Medical Association (JAMA), a theme issue on Global Health.

Ronald C. Kessler, Ph.D., from Harvard Medical School, Boston, presented the findings from the study today at a JAMA media briefing held at the National Press Club in Washington, D.C.

Co-Principal Investigators of the Survey, Dr. Kessler and Dr. T. Bedirhan Üstün from the World Health Organization, together with co-authors from The WHO World Mental Health Survey Consortium analyzed data from 60,463 face-to-face household surveys with adults in 14 countries (6 less developed, 8 developed) to estimate the prevalence, severity, and treatment of mental disorders. The surveys were conducted from 2001 - 2003 in the Americas (Columbia, Mexico, United States), Europe (Belgium, France, Germany, Italy, Netherlands, Spain, Ukraine), the Middle East and Africa (Lebanon, Nigeria), and Asia (Japan, separate surveys in Beijing and Shanghai in the People's Republic of China). The six countries classified as less developed by the World Bank are China, Colombia, Lebanon, Mexico, Nigeria, and Ukraine.

All surveys used the World Mental Health -Composite International Diagnostic Interview (WMH-CIDI), a structured diagnostic interview to assess disorders and treatment. Disorders considered included anxiety disorders, mood disorders, disorders that share a feature of problems with impulse control (for example, bulimia [episodic binge eating followed by compensatory behaviors]), and substance abuse disorders.

The researchers found that the prevalence of having any mental disorder in the prior year varied widely from 4.3 percent in Shanghai to 26.4 percent in the United States. "Between 33.1 percent (Columbia) and 80.9 percent (Nigeria) of 12-month cases were mild," the researchers report. "Serious disorders were associated with substantial role disability [inability to carry out usual activities]. Although disorder severity was correlated with probability of treatment in almost all countries, 35.5 percent to 50.3 percent of serious cases in developed countries and 76.3 percent to 85.4 percent in less-developed countries received no treatment in the 12 months before the interview." The authors continue, "Due to the high prevalence of mild and subthreshold cases, the number of those who received treatment far exceeds the number of untreated serious cases in every country." The term "subthreshold case" refers to people who received treatment even though they did not meet full criteria for a mental disorder.

"The fact that many people with subthreshold disorders are treated while many with serious disorders are not shows that unmet need for treatment among serious cases is not merely a matter of limited treatment resources but that misallocation of treatment resources is also involved," the authors comment. "To the extent that early intervention can prevent progression, early treatment might be cost effective. It is difficult to act on this insight, however, because we lack good information either about the characteristics of mild cases that predict risk of progression to more serious disorders or about the effectiveness of interventions for mild cases in preventing this progression. A new focus on development and evaluation of secondary prevention programs for the early treatment of mild cases is needed to guide rationalization of treatment resource allocation," the authors conclude.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Generative AI falls short in accurately identifying global health policies